Brent L Saunders Silverback Therapeutics, Inc. (SBTX) insider trading activity

SBTX Quotes by TradingView

Brent L Saunders is of Silverback Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 20, 2025, when has been sold 120,000 shares (Common Stock) at a price of $14.25 per share, resulting in proceeds of $1,710,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

BRENT L SAUNDERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2025
SELL
Open market or private sale
$1,710,000 $14.25 p/Share
120,000 Reduced 100.0%
0 Common Stock
May 20 2025
BUY
Exercise of conversion of derivative security
$121,200 $1.01 p/Share
120,000 Added 50.0%
120,000 Common Stock

Also insider at

CSCO
CISCO SYSTEMS, INC. Technology
Director
SKIN
Beauty Health Co Consumer Defensive
Director
BBIO
BridgeBio Pharma, Inc. Healthcare
Director
BLCO
Bausch & Lomb Corp Healthcare
CEO and Chairman of the Board
BLS

Brent L Saunders

San Jose, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SBTX